Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice

Completed

• Conditions: Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease

• Registration Number: NCT02322008
• Lead Sponsor: Regionshospitalet Viborg, Skive

Brief Summary

Can genetic markers be used to predict anti-TNF response? A cohort was established to identify SNPs associated with anti-TNF therapy in patients with inflammatory bowel disease.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-09
• Primary Completion: 2011-03
• Study Completion: 2011-03
• Status Verified: 2014-12
• Study First Submitted: 2014-12-17
• Study First Submitted QC: 2014-12-19
• Study First Posted: 2014-12-22
• Last Update Submitted: 2014-12-22
• Last Update Posted: 2014-12-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1035

Inclusion Criteria

• CD or UC, treated with anti-TNF

Exclusion Criteria

• Missing data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
3-step scale	22 weeks	Best response within 22 weeks